Skip to main content
. Author manuscript; available in PMC: 2010 Apr 22.
Published in final edited form as: Pharmacol Biochem Behav. 2008 Aug 23;91(2):261–270. doi: 10.1016/j.pbb.2008.08.018

Fig. 6.

Fig. 6

Represents percent of vehicle control for 3α,5α-THP concentrations in midbrain, hippocampus, striatum, cortex, and interbrain of E2-primed rats that received no infusions (white bars), or infusions of 3α,5α-THP to the VTA (black bars), SN (diagonally-striped bars), or CG (horizontally-striped bars). * indicates that rats infused with 3α,5α-THP to the VTA had significantly higher levels of 3α,5α-THP in midbrain (F4,38=25.00, P<0.05), hippocampus (F4,38=71.71, P<0.05), striatum (F4,38=6.27, P<0.05), and cortex (F4,38=11.01, P<0.05) compared to all other groups.